Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease

Citation
Dl. Hemsel et al., Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease, CLIN INF D, 32(1), 2001, pp. 103-107
Citations number
18
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
32
Issue
1
Year of publication
2001
Pages
103 - 107
Database
ISI
SICI code
1058-4838(20010101)32:1<103:CRTCFD>2.0.ZU;2-I
Abstract
The International-Infectious Disease Society for Obstetrics and Gynecology- USA (I-IDSOG-USA) has concerns about the most recently published Centers fo r Disease Control and Prevention (CDC) guidelines for pelvic inflammatory d isease (PID). I-IDSOG-USA advocates the following changes when the guidelin es are revised. We recommend the use of the term "upper genital tract infec tion" (UGTI), followed by the designation of the etiologic agent, instead o f the currently employed term, "pelvic inflammatory disease," or PID. In di agnoses, there should be greater emphasis on signs and symptoms related to subclinical or occult UGTI. Therapeutic recommendation for the treatment of UGTI should be documented for various stages of this diverse disease entit y. There should be greater emphasis on hospitalization for infected nulligr avida teenagers. This permits monitoring of antibiotic treatment and provid es a site for medical educational efforts to teach this medically underserv ed segment of our society how to protect their future fertility, their heal th, and their lives.